Mettler-Toledo International (NYSE:MTD) Updates Q3 2026 Earnings Guidance

Mettler-Toledo International (NYSE:MTD) updated its third quarter 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 12.000-12.150 for the period, compared to the consensus earnings per share estimate of 12.120. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Mettler-Toledo International also updated its FY 2026 guidance to 47.150-47.500 EPS.

Mettler-Toledo International Trading Up 2.7%

Shares of MTD traded up $37.94 on Friday, reaching $1,418.55. 257,216 shares of the company’s stock traded hands, compared to its average volume of 153,916. Mettler-Toledo International has a 52-week low of $1,023.05 and a 52-week high of $1,525.17. The stock has a market cap of $28.67 billion, a PE ratio of 31.93, a PEG ratio of 2.88 and a beta of 1.24. The stock’s 50 day simple moving average is $1,237.30 and its two-hundred day simple moving average is $1,276.04.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, July 30th. The medical instruments supplier reported $11.46 EPS for the quarter, topping analysts’ consensus estimates of $10.80 by $0.66. The company had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Mettler-Toledo International had a negative return on equity of 872.07% and a net margin of 21.91%.The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the previous year, the business posted $10.09 EPS. Mettler-Toledo International has set its FY 2026 guidance at 47.150-47.500 EPS and its Q3 2026 guidance at 12.000-12.150 EPS. Analysts forecast that Mettler-Toledo International will post 46.63 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on MTD shares. Citigroup dropped their price target on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Robert W. Baird dropped their price objective on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Stifel Nicolaus reduced their target price on shares of Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating for the company in a research note on Monday, May 18th. JPMorgan Chase & Co. dropped their price target on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Finally, Barclays reduced their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Six investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $1,420.36.

Trending Headlines about Mettler-Toledo International

Here are the key news stories impacting Mettler-Toledo International this week:

• Positive Sentiment: Quarterly earnings beat expectations: Adjusted EPS rose 14% year over year to $11.46, exceeding the $10.80 consensus estimate by $0.66. Revenue increased approximately 4% to $1.03 billion, in line with expectations, while reported EPS reached $11.55 versus $9.76 a year earlier. Mettler-Toledo Second-Quarter 2026 Results
• Positive Sentiment: Full-year outlook was raised: Mettler-Toledo now expects fiscal 2026 EPS of $47.15 to $47.50, above the prior consensus estimate of $46.64. The updated outlook supports expectations for continued earnings growth and helped strengthen the investment case. Mettler-Toledo Second-Quarter 2026 Results
• Positive Sentiment: Jefferies became more bullish: Jefferies Financial Group raised its price target from $1,400 to $1,580 and upgraded the stock to “buy,” implying roughly 11% upside from the referenced trading level. The upgrade provides additional positive analyst momentum. Benzinga analyst-upgrade report
• Neutral Sentiment: Third-quarter guidance was broadly in line: EPS guidance of $12.00 to $12.15 brackets the $12.12 consensus estimate, while revenue guidance of approximately $1.1 billion is consistent with expectations. This suggests steady performance but provides less of a near-term upside surprise than the full-year outlook.

Institutional Trading of Mettler-Toledo International

Institutional investors and hedge funds have recently modified their holdings of the business. Armistice Capital LLC purchased a new position in Mettler-Toledo International in the 3rd quarter worth approximately $303,000. Hardworking Capital Advisors LLC bought a new stake in shares of Mettler-Toledo International during the 4th quarter worth $286,000. EP Wealth Advisors LLC bought a new stake in shares of Mettler-Toledo International during the 2nd quarter worth $282,000. Compound Planning Inc. purchased a new position in Mettler-Toledo International in the fourth quarter worth $279,000. Finally, Focus Partners Advisor Solutions LLC bought a new position in Mettler-Toledo International in the fourth quarter valued at $246,000. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.